SS
TCRT icon

Sunbelt Securities’s Alaunos Therapeutics TCRT Stock Holding History

Sunbelt Securities’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29 Hold
10
– – ﹤0.01% 2840
2025
Q4 		$32 Hold
10
– – ﹤0.01% 2689
2025
Q3 		$24 Hold
10
– – ﹤0.01% 2646
2025
Q2 		$19 Hold
10
– – ﹤0.01% 1793
2025
Q1 		$15 Hold
10
– – ﹤0.01% 1783
2024
Q4 		$22 Buy
+10
New +$22 ﹤0.01% 1797
2020
Q3 		– Sell
-227
Closed -$112K – 345
2020
Q2 		$112K Hold
227
– – 0.04% 284
2020
Q1 		$83K Buy
+227
New +$117K ﹤0.01% 357

Other funds holding TCRT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sunbelt Securities's TCRT Position: Q1 2026 in Review

Sunbelt Securities held its Alaunos Therapeutics (TCRT) position steady in Q1 2026 at 10 shares worth $29. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

Sunbelt Securities first reported a position in TCRT in Q1 2020 and has held it in 8 quarters since. The position peaked at $112K in Q2 2020. 29 funds tracked by Wall St. Rank hold TCRT as of Q1 2026.

  • Sunbelt Securities held 10 shares of Alaunos Therapeutics worth $29 as of Q1 2026.
  • Sunbelt Securities left its Alaunos Therapeutics share count unchanged in Q1 2026.
  • Alaunos Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2840 holding.
  • Sunbelt Securities first reported a position in Alaunos Therapeutics in Q1 2020 and has held it in 8 quarters since.
  • Sunbelt Securities's Alaunos Therapeutics position peaked at $112K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.